ArticleGenes & genomics2026
Exome-wide screening discovers novel pathogenic variants in Vietnamese primary congenital glaucoma patients.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary congenital glaucoma (PCG), the most prevalent pediatric variant, is a major contributor of childhood blindness globally. Traditional diagnosis relies on clinical features such as the classic triad (epiphora, photophobia, and blepharospasm), elevated intraocular pressure (IOP), corneal enlargement and optic disc cupping. Early diagnosis remains challenging as the conventional diagnosis often requires cooperation from pediatric patients.
objectiveTo identify the genetic etiology and underlying variants in a cohort of Vietnamese patients diagnosed with PCG using WES.
methodsA cohort of 32 Vietnamese patients with clinically diagnosed PCG was subjected to Whole-Exome Sequencing (WES) for genetic etiology identification. Validation of candidate variants was achieved using Sanger sequencing, with pathogenicity classification following ACMG/AMP guideline.
resultsGenetic examination revealed pathogenic/likely pathogenic variants in 18.75% of the cohort (6/32 probands), involving in three genes: CYP1B1, TEK, FOXC1; and VUS in 6.25% (2/32 probands) spanning the gene LTBP2, FBN1. Three novel point variants in glaucoma-assiciated genes were identified, including a frameshift in FOXC1 (p.Tyr5fs*40), a stop-gained variant in TEK (p.Trp216*), and a missense variant in FBN1 (p.Lys54Glu). Additionally, a new putative large chromosomal deletion was identified on FOXC1 gene. While CYP1B1 remains a primary driver of PCG, finding alterations in FOXC1 and FBN1-typically associated with Axenfeld-Rieger and Marfan syndromes-underscores the clinical overlap between PCG and other developmental or systemic disorders.
conclusionAchieving a 25% diagnostic rate, the study suggests that broader genetic testing by WES would greatly beneficial in the identification and categorization of glaucoma. The data suggest that WES is a powerful diagnostic resource, particularly when corneal clouding impedes fundus examination, and can provide essential insights into systemic syndromic risks.
Indexed as
Identifiers
42758422What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.